Evaluation Of Phytoconstituents And Antioxidant Properties Of Polyherbal Formulations As Potential Antidiabetic Agents
Keywords:
Tinospora Cordifolia and Epipremnum aureum, phytochemical analysis and antioxidantAbstract
The aim of the study to investigate the phytochemical and antioxidant activity of polyherbal formulation in antidiabetic potential. Ethanolic extract of the polyherbal formulation was prepared by the Soxhlation process, Phytochemical screening, Total Phenolic Content and Total Flavonoid Content of the extracts were estimated using standard methods. Extracts were analysed for its antioxidant potential using DPPH, and Reducing power methods to assay their free scavenging activity. Results shows that plant extract (Tinospora Cordifolia and Epipremnum aureum) contains Flavonoids 0.65±0.03 and 55.2±0.05 mg/g, Total phenol 5.2±0.29mg/g and 8.3±0.19mg/g, preliminary phytochemical screening revealed the presence of tannins, alkaloids, flavonoids, glycosides. Antioxidant study for DPPH and reducing power of plant extract were 37.1±0.31, 47±0.28 and 88.99±0.22, 43.8±0.18, at 100µg/ml respectively. these findings may provide efficient, supportive data on the use of medicinal herbs for treatment of numerous health ailments associated with the accumulation of harmful free radicals and reactive oxygen species. It was concluded that flavonoids component were present in all solvent extracts of T. cordifolia and Epipremnum aureum. TFC was high in methanolic leaves extract of T. cordifolia and Epipremnum aureum. Furthermore, these results of plant sources were found to be highly significant. study has revealed that the ethanol extract of T cordifolia and Epipremnum aureum contains substantial amount of phenolics and thus, can be inferred that these phenolics are responsible for its marked antioxidant activity
Downloads
References
1.Das, S.K., Sengupta, P., Mustapha, M.S., Kifayatudullah, M. and Goussudin, M. 2015. Phytochemical investigation and antioxidant screening of crude leaves extract from Epipremnum aureum. Int. J. Pharmacognosy Phytochem. Res. 7(4): 684-689.
2. Kifayatullah, M. 2015. Toxicological investigation of ethanolic extract of Epipremnum aureum in rodents. J App Pharma Sci. 5: 57-61.
3. Kumudhaveni B, Radha R. Anti-diabetic potential of a traditional Polyherbal Formulation–A Review. Research journal of Pharmacy and Technology. 2017 Jun 1;10(6):1865.
4. Deore ND, Gupta S, Shrivastav B, Upasni CD, Apte KG, Shaikh AM. Anti-diabetic potential of a Polyherbal Formulation–A Review. Research Journal of Pharmacy and Technology. 2018 Jun 1;11(6):2625-30.
5. Anbari K, Sahraei N, Ahmadi SAY, Baharvand P. Barriers of breast cancer screening from the viewpoint of women in Khorramabad (West of Iran). Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2016. 7(6), pp. 2044-2049.
6. Nejad DB, Azandeh S, Gholami MR, Gharravi AM, Zhaleh M. Superficial palmar arch with Persistent median artery. Journal of the Anatomical Society of India.2016. 65(2), pp. 175-176.
7. Sane S. The Effect of intrathecal fentanyl on Bi-spectral index during spinal anesthesia in patients with lower limb orthopedic surgery. Journal of Global Pharma Technology.2016. 8(12), pp. 435-440.
8. Sane S, Khoshkbary M, Abbasyvash R, Mahoori AR. Evaluation of the effect of preoperative oral Tizanid in on the rate of anesthetic consumption & hemodynamic changes in Tiva (total intravenous anesthesia). Journal of Global Pharma Technology. 2016. 8(12), pp. 441-446
9. Uddandrao VS, Brahmanaidu P, Ganapathy S. Evaluation of the antioxidant and antidiabetic potential of the poly herbal formulation: identification of bioactive factors. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly. 2020 Nov 1;18(2):111-23.
10. Farhadifar F, Molina Y, Taymoori P, Akhavan S. Mediators of repeat mammography in two tailored interventions for Iranian women Health behavior, health promotion and society. BMC Public Health. 2016. 16(1).
11. Pillai GK, Bharate SS, Awasthi A, Verma R, Mishra G, Singh AT, Jaggi M, Mithal A, Vishwakarma RA. Antidiabetic potential of polyherbal formulation DB14201: Preclinical development, safety and efficacy studies. Journal of ethnopharmacology. 2017 Feb 2; 197:218-30.
12. Macooie AA, Nikibakhsh AA, Vatan AE, Rasmi Y. Comparing the serum total antioxidant capacity in children suffering from Henoch-Schönlein purpura in both active and remissive phase of the illness. Acta Medica Mediterranea. 2015. 31(7), pp. 1405-1409.
13. Sukalingam K, Ganesan K, Ponnusamy K. Evaluation of antidiabetic activity of polyherbal formulations on type 2 diabetic patients: A single blinded randomized study. Int. J. Intg. Med. Sci. 2015;2(3):90-8.
14. Darvishi M, Sadeghi SS. Evaluation of association of helicobacter pylori infection and coronary heart disease (chd) among ccu patients. (2016) Journal of Pure and Applied Microbiology, 10 (4), pp. 2621-2626.
15. Jain A, Jangid T, Jangir RN, Bhardwaj GS. Antidiabetic activity of polyherbal formulations: a comprehensive review: A. Jain et al. Protoplasma. 2025 Sep;262(5):1031-52.
16. Shanmugam SK, Gaur PK, Kumar D. A new antidiabetic polyherbal formulation for diabetes. The Thai Journal of Pharmaceutical Sciences. 2022;46(4):449-53.
17. Shanthi S, Faheem, Ghousiya S, Divakar M, Harish R. In vitro antioxidant and anti-diabetic evaluation of a polyherbal formulation.
18. Duraisami R, Sengottuvelu S, Prabha T, Sabbani S, Presenna SD, Muralitharan CK. Evaluation of antidiabetic efficacy of polyherbal formulations in experimentally induced hyperglycemic rats. Ann. Phytomed. 2021;10(2):286-91.
19. Begum N, Farman S, Shah SB, Afridi SG, Iqbal A, Nasir A, Iqbal J, Parveen Z. Development and characterization of polyherbal formulations for bioactive properties to target diabetes mellitus. Fresenius Environmental Bulletin. 2019 Jan 1;28(11):8889-99.
20. Bisht A, Dwivedi H, Rawat AK. Development and evaluation of Polyherbal formulation for diabetes. Asian Pac J Health Sci. 2021; 8:48-54.
21. Suvarna R, Shenoy RP, Hadapad BS, Nayak AV. Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus-A systematic review and meta-analysis. Journal of Ayurveda and integrative medicine. 2021 Jan 1;12(1):213-22.
22. Sahu U, Tiwari SP, Roy A. Comprehensive notes on anti-diabetic potential of medicinal plants and polyherbal formulation. Pharmaceutical and Biosciences Journal. 2015 Jun 30:57-64.
23. Sahu U, Tiwari SP, Roy A. Comprehensive notes on anti-diabetic potential of medicinal plants and polyherbal formulation. Pharmaceutical and Biosciences Journal. 2015 Jun 30:57-64.
24. Venkateswaran MR, Jayabal S, Murugesan S, Periyasamy S. Identification of polyphenolic contents, in vitro evaluation of antioxidant and antidiabetic potentials of a polyherbal formulation-Mehani. Natural product research. 2021 Aug 12;35(16):2753-7.
25. Saifi A, Chauhan R, Dwivedi J. Development of a polyherbal formulation FMST and evaluation for antidiabetic activity in alloxan induced diabetic rats. Asian Journal of Pharmaceutical Research. 2017 Mar 3;7(1):1-7.
26. Irudaya CD, Venkitaraman R, Srinivasan R, Moorthy S, Venkatesan U, Panneerselvam D. A novel polyherbal formulation for treating prediabetes and diabetes–an in vitro antioxidant, antidiabetic activity and phytochemical characterization. Asian J. Pharmacogn. 2023; 7:1-8.
27. Kiani Z, Hassanpour-Fard M, Asghari Z, Hosseini M. Experimental evaluation of a polyherbal formulation (Tetraherbs): antidiabetic efficacy in rats. Comparative Clinical Pathology. 2018 Nov;27(6):1437-45.
28. Shah SS, Manigauha A, Dubey B. Formulation and Evaluation of Antidiabetic and Antihyperlipidemic Activities of Polyherbal Formulation in Streptozotocin induced diabetic rat. Pharmaceutical and Biosciences Journal. 2019 Jan 22:26-30
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
